A discovery study on 167 mCRC patients receiving irinotecan also revealed a protective effect of the SLCO1B1 rs2291076 T allele against neutropenia but associated the rs2306283 GG genotype with significantly higher neutropenia events. This evidence concerns the gene SLCO1B1 and neutropenia.